LACUTAMAB
UNII N8O7MY0VNS

Substance Identification & Data

This profile provides standardized clinical and technical data for Lacutamab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) N8O7MY0VNS.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2187368-16-5 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

N8O7MY0VNS

CAS Registry Number

2187368-16-5

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

LACUTAMAB

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C124999

National Cancer Institute reference terminology for clinical and research data.

INN ID

10924

Sequential identifier assigned via the WHO International Nonproprietary Name program.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Lacutamab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

LACUTAMAB

Common Names & Synonyms

ANTI-KIR3DL2 MONOCLONAL ANTIBODY IPH4102

LACUTAMAB [INN]

LACUTAMAB [WHO-DD]

Systematic Nomenclature

IMMUNOGLOBULIN G1(240-ASPARTIC ACID, 333-GLUTAMIC ACID), ANTI-(HUMAN KILLER CELL IMMUNOGLOBULIN-LIKE RECEPTOR KIR3DL2) (HUMAN-MUS MUSCULUS MONOCLONAL IPH4102 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL IPH4102 .KAPPA.-CHAIN, DIMER

SYS